|
1
|
Ricard D, Idbaih A, Ducray F, Lahutte M,
Hoang-Xuan K and Delattre JY: Primary brain tumours in adults.
Lancet. 379:1984–1996. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Catt S, Chalmers A and Fallowfield L:
Psychosocial and supportive-care needs in high-grade glioma. Lancet
Oncol. 9:884–891. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wolff JE, Driever PH, Erdlenbruch B,
Kortmann RD, Rutkowski S, Pietsch T, Parker C, Metz MW, Gnekow A
and Kramm CM: Intensive chemotherapy improves survival in pediatric
high-grade glioma after gross total resection: Results of the
HIT-GBM-C protocol. Cancer. 116:705–712. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tsang DS, Murphy ES, Ezell SE, Lucas JT
Jr, Tinkle C and Merchant TE: Craniospinal irradiation for
treatment of metastatic pediatric low-grade glioma. J Neurooncol.
134:317–324. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang GL, Jiang BH, Rue EA and Semenza GL:
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS
heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci
USA. 92:5510–5514. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iyer NV, Kotch LE, Agani F, Leung SW,
Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY
and Semenza GL: Cellular and developmental control of O2
homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev.
12:149–162. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Masoud GN and Li W: HIF-1α pathway:
Role, regulation and intervention for cancer therapy. Acta Pharm
Sin B. 5:378–389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ranasinghe WK, Baldwin GS, Bolton D,
Shulkes A, Ischia J and Patel O: HIF1α expression under normoxia in
prostate cancer-which pathways to target? J Urol. 193:763–770.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu F, Zhang X, Yu Q, Han G, Diao F, Wu C
and Zhang Y: LncRNA AWPPH inhibits SMAD4 via EZH2 to regulate
bladder cancer progression. J Cell Biochem. 119:4496–4505. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao X, Liu Y and Yu S: Long noncoding RNA
AWPPH promotes hepatocellular carcinoma progression through YBX1
and serves as a prognostic biomarker. Biochim Biophys Acta Mol
Basis Dis. 1863:1805–1816. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ceccarelli M, Barthel FP, Malta TM,
Sabedot TS, Salama SR, Murray BA, Morozova O, Newton Y, Radenbaugh
A, Pagnotta SM, et al: Molecular profiling reveals biologically
discrete subsets and pathways of progression in diffuse glioma.
Cell. 164:550–563. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Y, Wu JJ, Lin XB, Bao Y, Chen ZH,
Zhang CR, Cai Z, Zhou JY, Ding MH, Wu XJ, et al: Differential
lncRNA expression profiles in recurrent gliomas compared with
primary gliomas identified by microarray analysis. Int J Clin Exp
Med. 8:5033–5043. 2015.PubMed/NCBI
|
|
14
|
Li J, Zhang M, An G and Ma Q: LncRNA TUG1
acts as a tumor suppressor in human glioma by promoting cell
apoptosis. Exp Biol Med (Maywood). 241:644–649. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma CC, Xiong Z, Zhu GN, Wang C, Zong G,
Wang HL, Er Bian B and Zhao B: Long non-coding RNA ATB promotes
glioma malignancy by negatively regulating miR-200a. J Exp Clin
Cancer Res. 35:902016.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Owonikoko TK, Arbiser J, Zelnak A, Shu HK,
Shim H, Robin AM, Kalkanis SN, Whitsett TG, Salhia B, Tran NL, et
al: Current approaches to the treatment of metastatic brain
tumours. Nat Rev Clin Oncol. 11:203–222. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Parrish KE, Sarkaria JN and Elmquist WF:
Improving drug delivery to primary and metastatic brain tumors:
Strategies to overcome the blood-brain barrier. Clin Pharmacol
Ther. 97:336–346. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin A, Li C, Xing Z, Hu Q, Liang K, Han L,
Wang C, Hawke DH, Wang S, Zhang Y, et al: The LINK-A lncRNA
activates normoxic HIF1α signalling in triple-negative breast
cancer. Nat Cell Biol. 18:213–224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kang Y, Zhu X, Xu Y, Tang Q, Huang Z, Zhao
Z, Lu J, Song G, Xu H, Deng C and Wang J: Energy stress-induced
lncRNA HAND2-AS1 represses HIF1α-mediated energy metabolism and
inhibits osteosarcoma progression. Am J Cancer Res. 8:526–537.
2018.PubMed/NCBI
|
|
20
|
El-Naggar AM, Veinotte CJ, Cheng H,
Grunewald TG, Negri GL, Somasekharan SP, Corkery DP, Tirode F,
Mathers J, Khan D, et al: Translational activation of HIF1α by YB-1
promotes sarcoma metastasis. Cancer Cell. 27:682–697. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Q, Li Y, Li J, Ma Y, Dai W, Mo S, Xu Y,
Li X and Cai S: FBW7 suppresses metastasis of colorectal cancer by
inhibiting HIF1α/CEACAM5 functional axis. Int J Biol Sci.
14:726–735. 2018. View Article : Google Scholar : PubMed/NCBI
|
